Ahjay ,interesting to see what if any plans they have for the melanoma trials in the future ,as the latest Goetz report stated that they currently didn’t attribute a value to this trial as they quoted “despite encouraging efficacy data ,seen in the phase 1 Tacti trial,immutep currently has no plans to develop this trial further.”
Was ,currently ,the operative word (time of which the article was written), is there perhaps some kind of deal in the making??
Ahjay ,interesting to see what if any plans they have for the...
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.5¢ |
Change
-0.025(7.58%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 32.3¢ | 30.5¢ | $1.286M | 4.143M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 190736 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 94190 | 21 |
View Market Depth
| Last trade - 13.59pm 26/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |
